Synthesis and biological evaluation of artemisinin derivatives as potential MS agents. 2022

Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
State Key Laboratory Basis of Xinjiang Indigenous Medicinal Plants Resource Utilization, and Key Laboratory of Plant Resources and Chemistry in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, South Beijing Road 40-1, Urumqi 830011, China; University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.

In this paper, a series of artemisinin derivatives were synthesized and evaluated. Studies have shown that IFN-γ produced by Th1 CD4+ T cells and IL-17A secreted by Th17 CD4+ T cells played critical roles in the treatment of multiple sclerosis. We used different concentrations of artemisinin derivatives to inhibit Th1 / Th17 differentiation in naive CD4+ T cells and to characterize IFN-γ / IL-17A in in vitro experiments. The preliminary screening results showed that ester compound 5 exhibited obvious inhibitory activities on Th1 and Th17 (IFN-γ decreased from 41% to 3% and IL-17A decreased from 24% to 8% at the concentration of 10 nM to 10 μM), and carbamate compounds also had obvious inhibitory activities against Th17 at high concentration. Moreover, we investigated the effect of compound 5 on myelin oligodendrocyte glycoprotein (MOG)-induced mice experimental autoimmune encephalomyelitis (EAE) model in vivo. 100 mg/kg compound 5 effectively reduced the disease severity of EAE compared with the vehicle group. This research revealed that compound 5 could be a promising avenue as potential MS inhibitor.

UI MeSH Term Description Entries
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D058504 Th17 Cells A subset of helper-effector T-lymphocytes which synthesize and secrete INTERLEUKINS IL-17; IL-17F; and IL-22. These cytokines are involved in host defenses and tissue inflammation in autoimmune diseases. T Helper 17 Cell,TH-17 Cell,Th17 Cell,Type 17 Helper T Cell,T Helper 17 Cells,TH-17 Cells,Type 17 Helper T Cells,Cell, TH-17,Cell, Th17,Cells, TH-17,Cells, Th17,TH 17 Cell,TH 17 Cells
D018417 Th1 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions. T Helper 1 Cells,TH-1 Cells,Type 1 Helper T Cells,Cell, TH-1,Cell, Th1,Cells, TH-1,Cells, Th1,TH 1 Cells,TH-1 Cell,Th1 Cell
D037621 Artemisinins A group of SESQUITERPENES and their analogs that contain a peroxide group (PEROXIDES) within an oxepin ring (OXEPINS).

Related Publications

Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
July 2018, Bioorganic & medicinal chemistry letters,
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
January 2011, European journal of medicinal chemistry,
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
September 2020, Journal of natural products,
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
June 2013, European journal of medicinal chemistry,
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
September 2022, ChemMedChem,
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
March 2011, Molecules (Basel, Switzerland),
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
February 2016, Molecules (Basel, Switzerland),
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
December 2011, European journal of medicinal chemistry,
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
October 2018, International journal of molecular sciences,
Yan Zhang, and Jie Lv, and Suqing Zhang, and Hanxi Yang, and Jingshan Shen, and Changsheng Du, and Xiangrui Jiang, and Haji A Aisa
August 2023, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!